Freda Stevenson
#126,836
Most Influential Person Now
Researcher
Freda Stevenson's AcademicInfluence.com Rankings
Freda Stevensonengineering Degrees
Engineering
#5013
World Rank
#6247
Historical Rank
Electrical Engineering
#1332
World Rank
#1423
Historical Rank
Freda Stevensoncomputer-science Degrees
Computer Science
#6399
World Rank
#6748
Historical Rank
Computational Linguistics
#1097
World Rank
#1111
Historical Rank
Machine Learning
#2066
World Rank
#2093
Historical Rank
Artificial Intelligence
#2326
World Rank
#2366
Historical Rank
Download Badge
Engineering Computer Science
Freda Stevenson's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Freda Stevenson Influential?
(Suggest an Edit or Addition)According to Wikipedia, Freda Kathryn Stevenson is a British immunologist and Professor at the University of Southampton. She was elected a Fellow of the Academy of Medical Sciences in 2000, and was the first British researcher to be awarded the American Society of Hematology Henry M. Stratton Medal.
Freda Stevenson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. (1999) (2637)
- CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. (2002) (677)
- Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia (1999) (426)
- DNA vaccines: precision tools for activating effective immunity against cancer (2008) (421)
- Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. (2003) (340)
- DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma (1998) (319)
- Chronic lymphocytic leukemia: revelations from the B-cell receptor. (2004) (265)
- Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. (1997) (259)
- B-cell receptor signaling in chronic lymphocytic leukemia. (2011) (250)
- Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. (2007) (249)
- Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. (2002) (240)
- ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia (2007) (228)
- VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. (1992) (219)
- Immunoglobulin V genes and CD38 expression in CLL. (2000) (196)
- Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype. (1991) (193)
- Chronic lymphocytic leukaemia (2017) (187)
- DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. (2009) (171)
- Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. (1994) (168)
- Bodyguards and assassins: Bcl‐2 family proteins and apoptosis control in chronic lymphocytic leukaemia (2005) (168)
- Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins (2010) (156)
- Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. (1998) (155)
- Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces. (1980) (154)
- V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. (1999) (150)
- Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1. (1987) (149)
- The occurrence and significance of V gene mutations in B cell-derived human malignancy. (2001) (136)
- Idiotypic DNA Vaccines Against B‐cell Lymphoma (1995) (135)
- Idiotypic vaccination as a treatment for a B cell lymphoma. (1988) (132)
- Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. (2006) (126)
- Antibody to a molecularly-defined antigen confined to a tumour cell surface (1975) (124)
- Insight into the origin and clonal history of B‐cell tumors as revealed by analysis of immunoglobulin variable region genes (1998) (122)
- Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity. (1995) (120)
- DNA vaccines to attack cancer (2004) (120)
- Electroporation as a “Prime/Boost” Strategy for Naked DNA Vaccination against a Tumor Antigen1 (2005) (116)
- Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus. (1993) (115)
- VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. (1996) (114)
- Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes (1994) (114)
- Human Follicular Lymphoma Cells Contain Oligomannose Glycans in the Antigen-binding Site of the B-cell Receptor* (2007) (113)
- DNA Fusion Vaccine Designed to Induce Cytotoxic T Cell Responses Against Defined Peptide Motifs: Implications for Cancer Vaccines1 (2001) (108)
- Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. (1996) (103)
- DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C. (1997) (103)
- Evidence for Involvement of a Hydrophobic Patch in Framework Region 1 of Human V4-34-Encoded Igs in Recognition of the Red Blood Cell I Antigen1 (2002) (100)
- Identification of normal B‐cell counterparts of neoplastic cells which secrete cold agglutinins of anti‐I and anti‐i specificity (1989) (100)
- Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment (1993) (99)
- Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. (1997) (98)
- Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells. (2012) (98)
- The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3. (1996) (98)
- Human Monoclonal Antibodies against Blood Group Antigens Preferentially Express a VH4‐21 Variable Region Gene‐Associated Epitope (1991) (97)
- Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors. (1986) (97)
- Preliminary studies for an immunotherapeutic approach to the treatment of human myeloma using chimeric anti-CD38 antibody. (1991) (96)
- The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. (2009) (96)
- Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch. (2004) (95)
- Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. (2002) (94)
- Immunogenetic analysis of the immune response to pneumococcal polysaccharide (2000) (93)
- Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire. (2003) (91)
- Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes (1980) (91)
- Critical Components of a DNA Fusion Vaccine Able to Induce Protective Cytotoxic T Cells Against a Single Epitope of a Tumor Antigen1 (2002) (90)
- Identification of the 9G4 idiotope in systemic lupus erythematosus. (1993) (90)
- The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy (2014) (89)
- DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time (2012) (88)
- Autoanti-red cell antibodies synthesized by patients with infectious mononucleosis utilize the VH4-21 gene segment. (1993) (87)
- DNA fusion gene vaccines against cancer: from the laboratory to the clinic (2004) (87)
- Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells. (1993) (87)
- IL-4 enhances expression and function of surface IgM in CLL cells. (2016) (85)
- Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. (1977) (84)
- Evidence for the overexpression of the VH4-34 (VH4.21) Ig gene segment in the normal adult human peripheral blood B cell repertoire. (1995) (84)
- Immunotherapy of hematologic malignancy. (2003) (82)
- Splenic lymphoma with villous lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes. (1995) (81)
- Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing. (2001) (81)
- Plant viral genes in DNA idiotypic vaccines activate linked CD4+ T-cell mediated immunity against B-cell malignancies (2001) (80)
- Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells. (2015) (79)
- DNA vaccines against cancer come of age. (2010) (79)
- Pharmacological inhibitors of NF-κB accelerate apoptosis in chronic lymphocytic leukaemia cells (2007) (78)
- Targeting B-cell anergy in chronic lymphocytic leukemia. (2012) (78)
- Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific. (2006) (76)
- A genetic approach to idiotypic vaccination. (1993) (74)
- PML-RARA–targeted DNA vaccine induces protective immunity in a mouse model of leukemia (2003) (73)
- Chronic lymphocytic leukaemia (2017) (72)
- Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines. (1999) (71)
- Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa‐associated lymphoid tissue lymphoma (2003) (66)
- Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function. (2013) (64)
- Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma. (2015) (62)
- Initial experience in treating human lymphoma with a chimeric univalent derivative of monoclonal anti-idiotype antibody. (1987) (62)
- Bystander stimulation of activated CD4+ T cells of unrelated specificity following a booster vaccination with tetanus toxoid (2010) (62)
- Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis. (1998) (61)
- Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo. (2010) (61)
- Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia. (2012) (61)
- Plant Virus Particles Carrying Tumour Antigen Activate TLR7 and Induce High Levels of Protective Antibody (2015) (61)
- Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: The molecule versus the mimic (2001) (60)
- Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation. (1983) (60)
- DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance. (2008) (59)
- Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells. (1996) (58)
- Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma. (1994) (57)
- Prospects for the treatment of B cell tumors using idiotypic vaccination. (1989) (56)
- Correlation of 9G4 idiotope with disease activity in patients with systemic lupus erythematosus (1998) (56)
- Anti-idiotypic therapy of leukemias and lymphomas. (1990) (52)
- Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. (2009) (52)
- Differential usage of an Ig heavy chain variable region gene by human B-cell tumors. (1993) (52)
- Recognition of a B cell lymphoma by anti-idiotypic T cells. (1990) (51)
- The effect of ions on the viscometric and ultracentrifugal behaviour of Tamm-Horsfall glycoprotein. (1971) (51)
- Pattern of usage and somatic hypermutation in the VH5 gene segments of a patient with asthma: Implications for IgE (1997) (51)
- Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma. (2008) (51)
- Analysis of Ig VH region genes encoding IgE antibodies in splenic B lymphocytes of a patient with asthma. (1995) (51)
- The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia (2016) (50)
- Dual recognition of lipid A and DNA by human antibodies encoded by the VH4-21 gene. A possible link between infection and lupus. (1995) (50)
- Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes (1976) (50)
- Rapid cytotoxicity of human B lymphocytes induced by VH4‐34 (VH4.21) gene‐encoded monoclonal antibodies (1996) (49)
- Idiotypic vaccination against B-cell lymphoma leads to dormant tumour. (1991) (48)
- Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses. (2010) (47)
- Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translation. (2016) (47)
- V(H) gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events. (1999) (47)
- Somatic mutation of bcl-6 genes can occur in the absence of V(H) mutations in chronic lymphocytic leukemia. (2000) (47)
- Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL. (2016) (46)
- The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemia. (2010) (45)
- Deregulated expression of the Myc cellular oncogene drives development of mouse "Burkitt-like" lymphomas from naive B cells. (2005) (45)
- Structural and Functional Features of the B-Cell Receptor in IgG-Positive Chronic Lymphocytic Leukemia (2006) (43)
- Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events. (2004) (43)
- Subunits of Tamm-Horsfall glycoprotein. (1970) (43)
- Critical influences on the pathogenesis of follicular lymphoma. (2018) (41)
- Urinary monoclonal free light chains in primary Sjögren's syndrome: an aid to the diagnosis of malignant lymphoma. (1986) (41)
- Selective expression of a VHIV subfamily of immunoglobulin genes in human CD5+ B lymphocytes from cord blood (1991) (41)
- Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia. (1987) (40)
- DNA vaccines and adjuvants (2004) (40)
- Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis. (1989) (39)
- Anti‐idiotype vaccines (2003) (39)
- Common Patterns of B Cell Perturbation and Expanded V4-34 Immunoglobulin Gene Usage in Autoimmunity and Infection (2004) (38)
- Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK. (2014) (38)
- Structural Analysis of VH4–21 Encoded Human IgM Allo‐ and Autoantibodies Against Red Blood Cells (1995) (38)
- VH gene analysis of clonally related IgM and IgG from human lymphoplasmacytoid B-cell tumors with chronic lymphocytic leukemia features and high serum monoclonal IgG. (1998) (38)
- V(H) gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo. (2002) (38)
- Prime-Boost with Alternating DNA Vaccines Designed to Engage Different Antigen Presentation Pathways Generates High Frequencies of Peptide-Specific CD8+ T Cells1 (2006) (38)
- Disturbances in peripheral blood B cell subpopulations in autoimmune patients (2002) (38)
- The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia. (2014) (37)
- The Immunoglobulin VH Gene, VH4–21, Specifically Encodes Autoanti‐Red Cell Antibodies against the I or i Antigens (1995) (37)
- Proteomic Analysis of Chronic Lymphocytic Leukemia Subtypes with Mutated or Unmutated Ig VH Genes* (2003) (37)
- The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model. (2015) (36)
- DNA vaccination against multiple myeloma. (1999) (36)
- Clonally related IgE and IgG4 transcripts in blood lymphocytes of patients with asthma reveal differing patterns of somatic mutation (1998) (36)
- Vaccination with DNA encoding a single-chain TCR fusion protein induces anticlonotypic immunity and protects against T-cell lymphoma. (2002) (35)
- Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event? (2006) (34)
- Immunogenetic analysis of the heavy chain variable regions of IgE from patients allergic to peanuts. (1998) (33)
- Use of phage surface expression to analyze regions of human V4-34(VH4-21)-encoded IgG autoantibody required for recognition of DNA: no involvement of the 9G4 idiotope. (1996) (33)
- Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells. (1993) (33)
- DNA fusion vaccines against B-cell tumors. (2001) (33)
- Mechanisms of tumour cell escape encountered in treating lymphocytic leukaemia with anti-idiotypic antibody. (1984) (33)
- DNA Fusion Vaccines Induce Targeted Epitope-Specific CTLs against Minor Histocompatibility Antigens from a Normal or Tolerized Repertoire1 (2004) (32)
- Unmutated immunoglobulin VH genes are associated with a more aggressive form of chronic lymphocyte leukemia (1999) (32)
- A plant-expressed conjugate vaccine breaks CD4+ tolerance and induces potent immunity against metastatic Her2+ breast cancer (2016) (31)
- Follicular lymphoma and the immune system: from pathogenesis to antibody therapy. (2012) (31)
- Origins of the malignant clone in typical Waldenstrom's macroglobulinemia. (2003) (30)
- A Pilot Study of Idiotypic Vaccination for Follicular B-cell Lymphoma Using a Genetic Approach. University of Bristol, Bristol, United Kingdom (1997) (29)
- PASD1 is a potential multiple myeloma-associated antigen. (2006) (29)
- The nature of the immunoglobulin G on the surface of B lymphocytes in chronic lymphocytic leukemia (1981) (29)
- DNA vaccines against cancer: from genes to therapy. (1999) (29)
- Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study (2015) (28)
- Surface immunoglobulin of guinea-pig leukaemic lymphocytes. (1975) (28)
- Rapid cytotoxicity of human B lymphocytes induced by VH4‐34 (VH4.21) gene‐encoded monoclonal antibodies, II (1997) (28)
- Patterns of somatic mutations in VH genes reveal pathways of clonal transformation from MGUS to multiple myeloma. (2003) (27)
- Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes (2016) (27)
- Public T Cell Receptor β-Chains Are Not Advantaged during Positive Selection1 (2008) (27)
- Tapasin shapes immunodominance hierarchies according to the kinetic stability of peptide – MHC class I complexes (2008) (27)
- Update on cancer vaccines (2005) (27)
- Prolonged Antigen Expression following DNA Vaccination Impairs Effector CD8+ T Cell Function and Memory Development1 (2007) (26)
- Differential usage of an autoantibody-associated VH gene, VH4-21, by human B-cell tumors. (1995) (26)
- VP22 enhances antibody responses from DNA vaccines but not by intercellular spread. (2005) (26)
- Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics. (1988) (26)
- Analysis of soluble HLA class II antigenic material in patients with immunological diseases using monoclonal antibodies. (1986) (26)
- Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model (2018) (25)
- What is the CLL B-lymphocyte? (1996) (25)
- Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help. (2005) (25)
- Monoclonal antibodies raised against the idiotype of the murine B cell lymphoma, BCL1 act primarily with heavy chain determinants. (1991) (25)
- Pattern of usage of the VH4-21 gene by B lymphocytes in a patient with EBV infection indicates ongoing mutation and class switching. (1995) (25)
- Monoclonal immunoglobulin light chain in urine of patients with B lymphocytic disease: its source and use as a diagnostic aid. (1983) (24)
- IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus (2017) (24)
- Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti‐idiotypic antibody responses (2002) (24)
- Vaccination Expands Antigen-Specific CD4+ Memory T Cells and Mobilizes Bystander Central Memory T Cells (2015) (23)
- DNA fusion vaccines enter the clinic (2011) (23)
- DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens. (2006) (23)
- Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin. (1977) (23)
- A Genetic Approach to Idiotypic Vaccination for B Cell Lymphoma a (1995) (23)
- Lymphokine-activated killer cells from normal and lymphoma subjects are cytotoxic for cells coated with antibody derivatives displaying human Fc gamma. (1988) (23)
- A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma. (1989) (22)
- Antibodies against urinary light chain idiotypes as agents for detection and destruction of human neoplastic B lymphocytes. (1983) (22)
- Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition (2014) (22)
- A γ‐herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope (2002) (22)
- Revisiting the definition of somatic mutational status in B-cell tumors: does 98% homology mean that a VH-gene is unmutated? (2004) (22)
- Lymphoma in Sjögren's syndrome: urinary monoclonal free light chains as a diagnostic aid and a means of tumour monitoring. (1986) (21)
- An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide. (2013) (21)
- Preparation and properties of FabIgG, a chimeric univalent antibody designed to attack tumour cells (1985) (21)
- Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients (2018) (20)
- DNA fusion gene vaccination mobilizes effective anti‐leukemic cytotoxic T lymphocytes from a tolerized repertoire (2008) (20)
- Secretion of immunoglobulin by neoplastic B lymphocytes from lymph nodes of patients with lymphoma. (1984) (20)
- The Genetic Basis of Human Vh4 Gene Family‐Associated Cross‐Reactive Idiotype Expression in CD5+ and CD5‐ Cord Blood B‐Lymphocyte Clones (1993) (20)
- Preparing the ground for vaccination against multiple myeloma. (2000) (20)
- The disaccharidase activity of a membrane fraction obtained from the rabbit renal cortex. (1972) (20)
- Consumption of monoclonal anti-idiotypic antibody by neoplastic B lymphocytes: a guide for immunotherapy. (1984) (19)
- A human b-cell lymphoma synthesizing and expressing surface mu-chain in the absence of detectable light chain. (1981) (19)
- Synergistic cytotoxic effects of antibodies directed against different cell surface determinants. (1978) (18)
- Immunoglobulin negative follicle centre cell lymphoma. (1984) (18)
- IgG‐secreting lymphoplasmacytoid leukaemia: a B‐cell disorder with extensively mutated VH genes undergoing Ig isotype‐switching frequently associated with trisomy 12 (2000) (18)
- Sequence analysis of immunoglobulin variable region genes that encode autoantibodies expressed by lymphomas of mucosa associated lymphoid tissue (1996) (18)
- A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. CRC NO: 92/33. Protocol NO: PH1/027. (1997) (17)
- A DNA Fusion Vaccine Induces Bactericidal Antibodies to a Peptide Epitope from the PorA Porin of Neisseria meningitidis (2007) (17)
- Anti-Idiotypic Therapy of Leukemias and Lymphomas (Part 1 of 2) (1990) (17)
- Public T cell receptor beta-chains are not advantaged during positive selection. (2008) (16)
- DNA gene fusion vaccines against cancer. (2002) (16)
- DNA fusion gene vaccines induce cytotoxic T‐cell attack on naturally processed peptides of human prostate‐specific membrane antigen (2011) (16)
- DNA fusion vaccine designs to induce tumor‐lytic CD8+ T‐cell attack via the immunodominant cysteine‐containing epitope of NY‐ESO 1 (2013) (16)
- Immunogenetic analysis reveals that epitope shifting occurs during B-cell affinity maturation in primary biliary cirrhosis. (2001) (16)
- Sequence analysis of V(4-34)-encoded antibodies from single B cells of two patients with systemic lupus erythematosus (SLE). (1998) (16)
- Immunogenetic analysis of a panel of monoclonal IgG and IgM anti-PDC-E2/X antibodies derived from patients with primary biliary cirrhosis. (1998) (15)
- IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution. (2020) (15)
- VH gene analysis of Burkitt's lymphoma in children from north‐western Iran (1998) (14)
- Isotype switch variants reveal clonally related subpopulations in diffuse large B-cell lymphoma. (2000) (14)
- Engineering DNA Vaccines that Include Plant Virus Coat Proteins (2003) (14)
- Cross-linking of lymphocytic surface immunoglobulin inhibits its production via a cyclic nucleotide mechanism (1979) (14)
- Polycythaemia rubra vera and hairy cell leukaemia in the same patient: studies on the spleen (1982) (14)
- New strategies for vaccination and imunomodulation in NHL (2001) (13)
- DNA vaccination: a potential weapon against infection and cancer (2001) (13)
- Secretion of idiotypic IgM by the mouse B-cell leukaemia (BCL1) occurs spontaneously in vitro and in vivo. (1985) (13)
- The export of immunoglobulin D by human neoplastic B lymphocytes (1983) (13)
- The viscosity of Tamm-Horsfall mucoprotein and its relation to cystic fibrosis. (1969) (13)
- Exploring the Pathways to Chronic Lymphocytic Leukemia. (2021) (12)
- IgM-expressing Waldenstrom's macroglobulinemia tumor cells reveal a potential for isotype switch events in vivo (2007) (12)
- Idiotypes and diseases. (1986) (12)
- Celebrating 20 Years of IGHV Mutation Analysis in CLL (2020) (12)
- A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1. (1999) (12)
- The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells. (2012) (12)
- Autoantibodies revealed: the role of B cells in autoimmune disease. (1999) (12)
- Problems and prospects in the use of lymphoma idiotypes as therapeutic targets (1988) (12)
- Biased utilization of immunoglobulin variable region heavy‐ and light‐chain genes by the malignant CD5‐ B lymphocytes from patients with Burkitt's lymphoma (1994) (11)
- Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination. (2016) (11)
- Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax (2005) (11)
- IL-10 Production By CLL Cells Is Enhanced in the Anergic IGHV Mutated Subset and Associates with Reduced DNA Methylation of the IL-10 Locus (2015) (11)
- Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells (2019) (11)
- Dual Recognition of Lipid A and DNA by Human Antibodies Encoded by the VH4‐21 Gene A Possible Link between Infection and Lupus a (1995) (11)
- Somatic mutation of bcl-6 genes can occur in the absence of VH mutations in chronic lymphocytic leukemia (2000) (11)
- Immunoglobulin produced by guinea-pig leukaemic B lymphocytes: its source and use as a monitor of tumour load. (1980) (11)
- Early stages in the ontogeny of small B‐cell lymphomas: genetics and microenvironment (2017) (10)
- Immunogenetics of human IgE. (1996) (10)
- Monoclonal anti-light chain idiotype as a tumor-specific probe for human neoplastic B lymphocytes (1987) (10)
- Determining mutational status of immunoglobulin v genes in chronic lymphocytic leukemia: a useful prognostic indicator. (2005) (9)
- VH gene sequences from a novel tropical splenic lymphoma reveal a naive B cell as the cell of origin (1999) (9)
- BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia (2019) (9)
- Studies on the cell surface maltase of the rabbit renal cortex. (1973) (9)
- Intronic BCL-6 mutations are preferentially targeted to the translocated allele in t(3;14)(q27;q32) non-Hodgkin B-cell lymphoma. (2003) (9)
- Higher levels of reactive oxygen species are associated with anergy in chronic lymphocytic leukemia (2015) (9)
- DNA vaccines against haematological malignancies. (1999) (9)
- Amplification of immune responses against a DNA-delivered idiotypic lymphoma antigen by fusion to the B subunit of E. coli heat labile toxin. (2009) (8)
- The PI 3 K / mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the E μ-TCL 1 mouse model (2015) (8)
- CHAPTER 25 – B Cells Producing Pathogenic Autoantibodies (2004) (8)
- Identification and assembly of V genes as idiotype-specific DNA fusion vaccines in multiple myeloma. (2005) (8)
- The immunological demonstration of an association between maltase activity and proximal tubular cell borders in the rabbit kidney. (1972) (8)
- Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells (2021) (8)
- A λ Bence-Jones protein in guinea pigs (1975) (8)
- The viscosity of Tamm-Horsfall mucoprotein. (1968) (7)
- Incidence of novel N‐glycosylation sites in the B‐cell receptor of lymphomas associated with immunodeficiency (2004) (7)
- Urinary excretion of CD23 antigen in normal individuals and patients with chronic lymphocytic leukaemia (CLL) (1991) (7)
- Mediation of cytotoxic functions by classes and subclasses of sheep antibody reactive with cell surface immunoglobulin idiotypic and constant region determinants. (1978) (7)
- DNA vaccination as cancer immunotherapy. (1997) (7)
- Further studies of immunoglobulin synthesis by guinea pig leukaemic lymphocytes. (1978) (7)
- Treatment of lymphoid tumors with anti-idiotype antibodies (2005) (7)
- Update on tumor vaccines (1992) (7)
- PEITC-mediated inhibition of mRNA translation is associated with both inhibition of mTORC1 and increased eIF2α phosphorylation in established cell lines and primary human leukemia cells (2016) (6)
- The relevance of sequence insertions in the Mcl-1 promoter in chronic lymphocytic leukemia and in normal cells. (2005) (6)
- Tumor vaccines. (2004) (6)
- Introduction: immunotherapy for multiple myeloma--insights and advances. (1999) (6)
- Anti‐j: Human Cold Agglutinins Recognizing Linear (i) and Branched (I) Type 2 Chains (1994) (6)
- High-affinity memory B cells induced by conjugate vaccines against weak tumor antigens are vulnerable to nonconjugated antigen. (2011) (6)
- Characterisation of a light chain loss variant of the BCL1 lymphoma. (1991) (5)
- Therapeutic strategies for B cell malignancies involving idiotype-anti-idiotype interactions. (1986) (5)
- Harnessing innate immunity to suppress lymphoma. (2010) (5)
- CD3+ CD8+ T cell lymphocytosis masking B cell leukaemia. (1988) (5)
- Optimizing cancer immunotherapy trials: Back to basics (2006) (5)
- IDIOTYPIC IMMUNOGLOBULIN PRODUCTION BY HUMAN NEOPLASTIC B LYMPHOCYTES: ITS USE IN MONITORING CHEMOTHERAPY AND IMMUNOTHERAPY11This work was supported by grants from Tenovus of Cardiff, the Medical Research Council and the Cancer Research Campaign, U.K. (1982) (5)
- Pattern of Usage of the VH4–21 Gene by B Lymphocytes in a Patient with EBV Infection Indicates Ongoing Mutation and Class Switching a (1995) (5)
- Understanding and activating immunity against human cancer. (2010) (5)
- Use of a cross reacting anti-idiotype to identify normal counterparts of neoplastic cells. (1988) (5)
- Peripheral blood stem cell autografts in myeloma. (1990) (5)
- β2‐Microglobulin from Normal and Leukaemic Guinea‐Pig Lymphocytes (1978) (4)
- A subset of mantle cell lymphoma exhibits stable disease and correlates with mutated VH genes and low CD38 expression (2001) (4)
- B-cell receptor signaling induces proteasomal degradation of PDCD4 via MEK1/2 and mTORC1 in malignant B cells (2022) (4)
- Correlation of 9 G 4 idiotope with disease activity in patients with systemic lupus erythematosus (1998) (4)
- High Surface IgM Levels Associate with Shorter Response Duration and Bypass of the BTK Blockade during Ibrutinib Therapy in CLL Patients (2019) (4)
- Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior. (2021) (4)
- Immunotherapy for multiple myeloma: insights from other models. (2002) (4)
- Vaccination against cancer. (1997) (4)
- Failure of Vaccination With Idiotypic Protein or DNA, (+/−IL-2), the Depletion of Regulatory T Cells, or the Blockade of CTLA-4 to Prolong Dormancy in Mice With BCL1 Lymphoma (2005) (4)
- Generation of lymphokine activated killer cells in a totally closed system (1987) (4)
- The Syk\Jak Inhibitor Cerdulatinib (PRT062070) Shows Promising Preclinical Activity in Chronic Lymphocytic Leukemia By Antagonising B Cell Receptor and Microenvironmental Signalling (2015) (3)
- Use of a Phage Expression System to Produce Fabs from Human Autoanti‐DNA Antibodies Encoded by the VH4–21 Gene Segment (1995) (3)
- Antibody activity in the presence of urea or guanidine. (1967) (3)
- Clinical and immunological responses to a DNA fusion vaccine in patients with carcinoembryonic antigen-expressing tumors: A Cancer Research UK phase I/II study. (2010) (3)
- B cell maturation in relation to multiple myeloma. (1999) (3)
- ARISING FROM HUMAN LEUKEMIC B LYMPHOCYTES (1980) (3)
- DNA vaccination against cancer antigens. (2000) (3)
- treatment of human myeloma using chimeric anti-CD38 antibody Preliminary studies for an immunotherapeutic approach to the (2011) (3)
- Introduction to a review series on therapeutic antibodies. (2018) (3)
- Idiotype gene rescue in follicular lymphoma. (2005) (3)
- Polycythemia rubra vera and hairy cell leukemia. (1985) (2)
- Polycythemia rubra vera and Hairy Cell Leukaemia / Reply (1985) (2)
- Lineage complexity in multiple myeloma? (2006) (2)
- High incidence of novel N-glycosylation sites in the immunoglobulin variable region genes of follicular lymphoma (2002) (2)
- DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity (2021) (2)
- Chronic lymphocytic leukemia : revelations from the B-cell receptor Running title : The B-cell receptor in CLL (2004) (2)
- DNA Vaccines against B-cell tumors (2000) (2)
- Introduction to a review series on advances in cell-based immune therapeutics in hematology. (2016) (2)
- Global and MYC-Specific Translation Is Enhanced in Activated Chronic Lymphocytic Leukemia Cells Carrying NOTCH1 C.7541_7542delct Mutations (2016) (2)
- Vaccine Therapy in NHL: Future Promises and Current Limitations (2003) (2)
- - 1-B-cell receptor signaling in chronic lymphocytic leukemia (2011) (2)
- Heterogeneity in neoplastic cell populations in chronic lymphocytic leukaemia defined by immunoglobulin expression and secretion in vitro. (1988) (2)
- Protein-polysaccharide complexes secreted by the calf tracheal epithelium in vitro. (1969) (2)
- Hodgkin's disease--new insights from immunoglobulin genetics. (1995) (2)
- Phage surface expression for analysis of recognition sites of human autoantibodies: comparison of single chain Fv and Fab. (1997) (2)
- DNA vaccination: genes versus cancer (2001) (2)
- Genetic analysis of IgE. (1996) (2)
- Chronic lymphocytic leukaemia and normal B lymphopoiesis. (1984) (2)
- Chapter 11 – Cancer Vaccines (2007) (2)
- Isolation and EBV-transformation of a minor population of normal human tonsillar B cells bearing a cold agglutinin-associated idiotope. (1990) (1)
- Use of Phage Expression to Analyze Regions of a Human V4‐34(VH4‐21)‐encoded IgG Autoantibody Required for Recognition of DNA No Involvement of the 9G4 Idiotope a (1997) (1)
- Lymphoma-Specific Subversion of B-Cell Receptor Signaling By Macrophage Lectins (2018) (1)
- ALLERGEN RECOGNITION SITES IN IMMUNOGLOBULIN E FROM PATIENTS WITH ASTHMA (1998) (1)
- Biological Significance of B Cell Receptor Mediated Regulation of Autophagy in Chronic Lymphocytic Leukemia (2015) (1)
- Integrated Analysis of IGHV Gene Status, Cell-of-Origin Signature and Genomic Features in Diffuse Large B-Cell Lymphoma (2016) (1)
- Genetic Vaccines against Cancer (2013) (1)
- VaccinesPeptide Motifs: Implications for Cancer Cytotoxic T Cell Responses Against Defined DNA Fusion Vaccine Designed to Induce (2001) (1)
- Chemical Activation of the SHIP1 Inositol Lipid Phosphatase: A Novel Therapeutic Strategy to Suppress B-Cell Receptor Signaling and CXCR4 Expression in Malignant Human B Cells (2016) (1)
- Lymphokine-Activated Killer Cells From Normal and Lymphoma Subjects Are Cytotoxic for Cells Coated With Antibody Derivatives Displaying Human Fc (2005) (1)
- Abstract 1871: Development of pelorol analogues to activate the SHIP1 lipid phosphatase; a novel paradigm to suppress B-cell receptor signaling in human B-cell cancers (2018) (1)
- High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL (2022) (1)
- Anti-Idiotypic Therapy of Leukemias and Lymphomas (Part 2 of 2) (1990) (1)
- patterns characteristic of unmutated CLL derived B-cell repertoire contains stereotypic IGHV1-69 The normal (2010) (1)
- Mannosylation of the Tumor Immunoglobulin Variable Region Informs Cell of Origin and Environmental Interactions in DLBCL Subsets (2019) (1)
- IgM+ B-Cells Lacking CD27 Expression Display Somatically Mutated Ig VH Genes and Define a New Memory Population. (2007) (0)
- Plasmid vaccination for B-cell lymphoma (1995) (0)
- development of mouse ''Burkitt-like'' lymphomas from naive B cells Deregulated expression of the Myc cellular oncogene drives (2013) (0)
- Comparison ofserum andsynovial fluid concentrations of02-microglobulin andC reactive protein in relation toclinical disease activity andsynovial inflammation inrheumatoid arthritis (1989) (0)
- weak tumor antigens are vulnerable to nonconjugated antigen High-affinity memory B cells induced by conjugate vaccines against (2011) (0)
- Preferential expression of CD180 by B cell chronic lymphocytic leukaemia (B-CLL) cells using IgVh mutated than those using IgVh unmutated genes (2003) (0)
- Correlation of the 9G4 idiotope (9G4(ld)) with disease activity in patients with systemic lupus erythematosus. (1997) (0)
- Phenethyl Isothiocyanate (PEITC) Regulates Autophagy in Chronic Lymphocytic Leukemia (2012) (0)
- Tumor vaccines (1991) (0)
- masking B cell leukaemia . CD 3 + CD 8 + T cell lymphocytosis (0)
- Modulation of B Cell Receptor Signalling By IL-4 In Chronic Lymphocytic Leukaemia (2013) (0)
- DNA vaccines to suppress myeloma (2007) (0)
- Involvement of innate and induced anti-idiotypic mechanisms in suppression of B cell tumors. (1987) (0)
- A DNA vaccine for HCV. (2001) (0)
- AntigenCells Against a Single Epitope of a Tumor T Vaccine Able to Induce Protective Cytotoxic Critical Components of a DNA Fusion (2002) (0)
- Advantaged during Positive Selection -Chains Are Not β Public T Cell Receptor (2013) (0)
- CD3+ CD8+ Tcell lymphocytosis masking Bcell leukaemia (1988) (0)
- B-cell receptor dependent phagocytosis and presentation of particulate antigen by chronic lymphocytic leukemia cells (2022) (0)
- Vaccin anticancéreux her2/neu (2014) (0)
- large B-cell lymphoma Isotype switch variants reveal clonally related subpopulations in diffuse (2013) (0)
- BETA-2-MICROGLOBULIN FROM NORMAL AND LEUKEMIC GUINEA-PIG LYMPHOCYTES (1978) (0)
- Analysis of immunoglobulin variable region heavy (VH) and light (VL) chain gene products in paraproteins isolated from Iranian patients with multiple myeloma (1997) (0)
- Analysis of Immunoglobulin Changes in Lymphoproliferative Diseases (1990) (0)
- Vulnerability of a vaccine-induced anti-tumor B-cell response to soluble protein antigen in the absence of T cell help (2006) (0)
- Activation of B-CLL cells by CD180 monoclonal antibodies: responders and non-responders (2003) (0)
- Quantitative determination of xylose in mucopolysaccharide derivatives. (1967) (0)
- Introduction to a review series on biological insights into lymphoid tumors. (2018) (0)
- PF526 STRUCTURAL AND FUNCTIONAL VARIABILITY OF THE TUMOR B-CELL RECEPTOR INDICATES A ROLE FOR ENVIRONMENTAL INFLUENCES ON BEHAVIOR OF MANTLE CELL LYMPHOMAS (2019) (0)
- memory T cells but antibody production remains vaccine specific Vaccination of human subjects expands both specific and bystander (2013) (0)
- BTK-independent regulation of calcium signalling downstream of the B-cell receptor in malignant B-cells. (2022) (0)
- DC-SIGN Binding to the Oligomannose-Type Glycans on the Surface Immunoglobulin Variable Region of Follicular Lymphoma Promotes Selective Adhesion to Microenvironmental VCAM-1 (2022) (0)
- Surface IgM Levels Independently Influence Clinical Behavior and Associate with Altered Phenotype and Genetics in Chronic Lymphocytic Leukemia (2014) (0)
- Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL (2022) (0)
- The variable regulatory B10 capacity of Chronic Lymphocytic Leukemias associates with B-cell receptor anergy and epigenetic programming (2015) (0)
- Introduction to a review series on small molecule targeted therapies for lymphoid malignancies. (2021) (0)
- Idiotypic plasmid vaccination for follicular B-cell lymphoma (1994) (0)
- Ameliorations relatives a la modification de reponse immunitaire (1993) (0)
- Molecular Vaccines in Infection and Cancer (1996) (0)
- Tracking the malignant cell of origin in Waldenstrom's macroglobulinemia (2007) (0)
- Dynamics of activation induced cytidine deaminase expression in t(11;14) mantle cell lymphoma (2005) (0)
- - 1-Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia (2011) (0)
- cTAGE are potential multiple myeloma associated antigens [In: Cancer immunotherapy 2006 meets strategies for immunetherapy p.414] (2007) (0)
- Function and Memory Development T Cell + Vaccination Impairs Effector CD8 Prolonged Antigen Expression following DNA (2007) (0)
- 70 Immunology of MDS, towards a DNA vaccine (1997) (0)
- transformation from MGUS to multiple myeloma Patterns of somatic mutations in VH genes reveal pathways of clonal (2013) (0)
- Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global RNA translation and translation of MYC RNA (2016) (0)
- IgM-expressing Waldenstrom's Macroglobulinemia tumor cells reveal a potential for isotype switch (2005) (0)
- Regulation of B-Cell Receptor Signalling By the Tumour Microenvironment in Chronic Lymphocytic Leukemia (CLL) and Its Impact on Adhesion and miRNA Expression (2016) (0)
- DNA fusion vaccines against B-cell tumors. (2000) (0)
- Characteristics of surface IgG expressed by a common adult human B-cell leukaemia (2004) (0)
- STRUCTURAL AND FUNCTIONAL VARIABILITY OF THE TUMOR B-CELL RECEPTOR INDICATES A ROLE FOR ENVIRONMENTAL INFLUENCES ON BEHAVIOR OF MANTLE CELL LYMPHOMAS (2019) (0)
- derivative of monoclonal anti-idiotype antibody Initial experience in treating human lymphoma with a chimeric univalent (2011) (0)
- Early Enhancement of IgM Expression and Signaling Capacity during Ibrutinib Therapy in CLL Patients (2016) (0)
- Identi fi cation in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function (2013) (0)
- DNA vaccines & adjuvants (2004) (0)
- Materials and procedures with respect to immune responses against fusion proteins (2001) (0)
- Activation and Proliferation of B Cell Chronic Lymphocytic Leukaemia (B-CLL) Cells through Anti-CD180, Anti-CD40 and IL-4. (2004) (0)
- Humoral effector mechanisms in the immunity to cancer. (1990) (0)
- Increased Reactive Oxygen Species and the B-Cell Receptor in Chronic Lymphocytic Leukemia Signaling (2014) (0)
- Immunoglobulin Variable Region Gene Sequences Reveal N-Glycosylation Motifs As an Early and Stable Event in Follicular Lymphoma Pathology (2018) (0)
- Acquisition of Mannoses on the Surface Immunoglobulin Binding Site Reveals Functional Status and Cell of Origin in Diffuse Large B Cell Lymphomas (2018) (0)
- Kostas patterns characteristic of unmutated CLL derived B-cell repertoire contains stereotypicIGHV 169 The normal (2009) (0)
- The Dual PI3K/mTOR Inhibitor PF-04691502 Induces Substantial Apoptosis in Chronic Lymphocytic Leukemia Cells in Vitro and Prolongs Survival in the Eµ-TCL1 Mouse Model (2014) (0)
- IL-4 Exerts Opposing Effects on Surface-IgM and CXCR4 Mediated Signalling in Chronic Lymphocytic Leukaemia (2014) (0)
- 210 Induction of apoptosis in chronic lymphocytic leukaemia by inhibition of NF-kB and novel sulfasalazine analogues (2004) (0)
- Changes During Disease Progression Somatic Mutation and Multiple Isotype Transcripts in Early Disease With Analysis of VH Genes in Follicular and Diffuse Lymphoma Shows Ongoing (2013) (0)
- Glycosylation of V region genes in follicular lymphoma as a result of the somatic hypermutation mechanism (2002) (0)
- Introduction to a Review Series on Understanding and Treating Primary Immunodeficiency. (2020) (0)
- Molecular vaccines in infection and cancer. (1996) (0)
- Anti-idiotypic immunity and tumour dormancy in a mouse B-cell lymphoma (1987) (0)
- B cells: formation and structure of autoantibodies (1999) (0)
- Monoclonal anti-light chain idiotype as a tumor-specific probe for human neoplastic B lymphocytes. (1987) (0)
- neoplastic B lymphocytes Monoclonal anti-light chain idiotype as a tumor-specific probe for human (2011) (0)
- Histocompatibility Antigens from a Normal Epitope-Specific CTLs against Minor DNA Fusion Vaccines Induce Targeted Simpson and (2004) (0)
- Monoclonal anti light chain idiotype as a tumor specific probe for human b cell lymphoma (1987) (0)
- chronic lymphocytic leukemia cells Surface IgM stimulation induces MEK1/2-dependent MYC expression in (2012) (0)
- A “Universal” Lectin-Mediated Interaction Drives B-Cell Receptor Signaling In Primary Follicular Lymphoma Cells (2013) (0)
- A gamma Bence-Jones protein in guinea pigs. (1975) (0)
- Activation of B-CLL cells by anti CD180 monoclonal antibodies: Responder and non-responder patients. (2003) (0)
- human B cell tumors Antibodies to shared idiotypes as agents for analysis and therapy for (2011) (0)
- Antigen V 4-34-Encoded Igs in Recognition of the Red Patch in Framework Region 1 of Human Evidence for Involvement of a Hydrophobic (2002) (0)
- Immunogenetic features of diffuse and follicular lymphoma vary with disease status and reveal multiple isotype expression (1997) (0)
- Surface IgM of Chronic Lymphocytic Leukemia Cells Displays Unusual Glycans Indicative of Antigen Engagement In Vivo. (2009) (0)
- Idiotypic vaccination against low grade follicular B cell lymphoma (1996) (0)
- Turning genes into cancer vaccines. (2005) (0)
- Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunological and Clinical Outcomes Running Title: Anti-CEA DNA Fusion Vaccination (2016) (0)
- Immunogenetic analysis of human monoclonal antimitochondrial antibodies reveals a lambda light chain bias and evidence of antigen-driven affinity maturation (1997) (0)
- clinical relevance DNA vaccination induces WT1-specific T-cell responses with potential (2008) (0)
This paper list is powered by the following services:
Other Resources About Freda Stevenson
What Schools Are Affiliated With Freda Stevenson?
Freda Stevenson is affiliated with the following schools:
